Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced the signing of a Securities Purchase Agreement with David Lazar, a private investor specializing in turnaround situations of distressed Nasdaq and NYSE companies.
The agreement represents a strategic investment by Mr. Lazar in Indaptus Therapeutics, consistent with his investment philosophy of identifying undervalued companies and working actively with management to restore shareholder value.